Trial registration number
|
NCT04799743 |
Full text link
Last imported at : March 18, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
https://clinicaltrials.gov/show/NCT04799743
|
First author
Last imported at : March 18, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Zhong Linda, MD.,PH.D
|
Contact
Last imported at : March 18, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
ldzhong0305@gmail.com
|
Registration date
Last imported at : March 18, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
2021-03-16
|
Recruitment status
Last imported at : July 4, 2023, 8 p.m.
Source : ClinicalTrials.gov
|
Unknown
|
Study design
Last imported at : March 18, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
RCT
|
Allocation
Last imported at : March 18, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Randomized
|
Design
Last imported at : March 18, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Parallel
|
Masking
Last imported at : March 18, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Blind label
|
Center
Last imported at : March 15, 2023, 4 a.m.
Source : ClinicalTrials.gov
|
single-center
|
Study aim
Last imported at : March 18, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Long covid
|
Inclusion criteria
Last imported at : March 18, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
inclusion criteria:
- participants will be the patients aged 18-65 years old who have been previously
diagnosed to be infected with covid-19 and discharged from local hospitals after
treatment with western medicines, and with negative results from covid-19 virus
detection. the subjects will be evaluated for potential pulmonary fibrosis and those
who present with the condition resulting from covid-19 infection will be included.
|
Exclusion criteria
Last imported at : March 18, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
- participants will be excluded if they have one or more of the followings: 1) inability
to communicate (e.g. cognitive impairment); 2) history of chinese medicine allergies;
3) incompetent in giving consent.
|
Number of arms
Last imported at : March 18, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
2
|
Funding
Last imported at : March 18, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Hong Kong Baptist University
|
Inclusion age min
Last imported at : March 18, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
18
|
Inclusion age max
Last imported at : March 18, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
65
|
Countries
Last imported at : March 18, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Hong Kong
|
Type of patients
Last imported at : March 18, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Patients recovered from covid
|
Severity scale
Last imported at : March 18, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
N/A
|
Total sample size
Last imported at : March 18, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
30
|
primary outcome
Last imported at : March 18, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Borg Category-Ratio 0-10 Scale;PRO scores;The handheld basic spirometry
|
Notes
Last imported at : March 18, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
None
|
Phase
Last imported at : Nov. 16, 2021, 6:30 p.m.
Source : ClinicalTrials.gov
|
Not reported
|
Arms
Last imported at : March 18, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
[{"arm_notes": "", "treatment_id": 1116, "treatment_name": "Resveratrol", "treatment_type": "Nutrition", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]
|